Article Text

Download PDFPDF

Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial
  1. Tom D Thacher1,
  2. Philip R Fischer2,
  3. John M Pettifor3
  1. 1Department of Family Medicine, Mayo Clinic, Rochester, Minnesota, USA
  2. 2Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA
  3. 3MRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, University of the Witwatersrand, Johannesburg, South Africa
  1. Correspondence to Dr Tom D Thacher, Department of Family Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; thacher.thomas{at}mayo.edu

Abstract

Objective To determine whether children with calcium-deficiency rickets have a better response to treatment with vitamin D and calcium than with calcium alone.

Design Randomised controlled trial.

Setting Jos University Teaching Hospital, Jos, Nigeria.

Population Nigerian children with active rickets treated with calcium carbonate as limestone (approximately 938 mg elemental calcium twice daily) were, in addition, randomised to receive either oral vitamin D2 50 000 IU (Ca+D, n=44) or placebo (Ca, n=28) monthly for 24 weeks.

Main outcome measure Achievement of a 10-point radiographic severity score ≤1.5 and serum alkaline phosphatase ≤350 U/L.

Results The median (range) age of enrolled children was 46 (15–102) months, and baseline characteristics were similar in the two groups. Mean (±SD) 25-hydroxyvitamin D (25(OH)D) was 30.2±13.2 nmol/L at baseline, and 29 (43%) had values <30 nmol/L. Baseline alkaline phosphatase and radiographic scores were unrelated to vitamin D status. Of the 68 children (94% of original cohort) who completed 24 weeks of treatment, 29 (67%) in the Ca+D group and 11 (44%) in the Ca group achieved the primary outcome (p=0.06). Baseline 25(OH)D did not alter treatment group effects (p=0.99 for interaction). At the end of 24 weeks, 25(OH)D values were 55.4±17.0 nmol/L and 37.9±20.0 nmol/L in the Ca+D and Ca groups, respectively, (p<0.001). In the Ca+D and Ca groups, the final 25(OH)D concentration was greater in those who achieved the primary outcome (56.4±17.2 nmol/L) than in those who did not (37.7±18.5 nmol/L, p<0.001).

Conclusions In children with calcium-deficiency rickets, there is a trend for vitamin D to improve the response to treatment with calcium carbonate as limestone, independent of baseline 25(OH)D concentrations.

Trial registration number ClinicalTrials.gov NCT00949832.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles